TELA Bio, Inc. Accounts Receivable, Allowance for Credit Loss, Current
TELA Bio, Inc. (TELA) had Accounts Receivable, Allowance for Credit Loss, Current of $522.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss, Current $522.00K.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $424.00K.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $287.00K.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $239.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $522.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $424.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $287.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $239.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $263.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $267.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $275.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $230.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $298.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $303.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $416.00K 10-K · filed 2025-03-21 |
| 2022-12-31 | $143.00K 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |